PSTV - Plus Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-07-22    (Delayed quote data   2026-02-10)
Last
 0.26		 Change
 ⇑ +0.01   (+0.00%)		 Volume
  8,057,797
Open
 0.26		 High
 0.28		 Low
 0.26
8EMA (Daily)
 0.25		 40EMA (Daily)
 0.38		 50EMA (Daily)
 0.40		 STO (Daily)
 34.545		 MACD Hist (Daily)
 0.016
8EMA (Weekly)
 0.351		 40EMA (Weekly)
 0.57		 50EMA (Weekly)
 0.65		 STO (Weekly)
 6.360		 MACD Hist (Weekly)
 -0.040
Company Profile
Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com